UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 205

Sortiert nach

RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2

Hepatology (Baltimore, Md.), 2018-06, Vol.67 (6), p.2254-2270

2018

Volltextzugriff (PDF)

Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma

Cancer, 2009-10, Vol.115 (19), p.4576-4585

2009

Volltextzugriff (PDF)

Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26

Hepatology (Baltimore, Md.), 2016-09, Vol.64 (3), p.797-813

2016

Volltextzugriff (PDF)

Aberrant Super‐Enhancer Landscape in Human Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2019-06, Vol.69 (6), p.2502-2517

2019

Volltextzugriff (PDF)

Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2016-08, Vol.64 (2), p.473-487

2016

Volltextzugriff (PDF)

Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis

Hepatology (Baltimore, Md.), 2012-08, Vol.56 (2), p.622-631

2012

Volltextzugriff (PDF)

C‐terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by c‐jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2013-01, Vol.57 (1), p.131-139

2013

Volltextzugriff (PDF)

Up‐regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis

Hepatology (Baltimore, Md.), 2016-02, Vol.63 (2), p.474-487

2016

Volltextzugriff (PDF)

Lysyl oxidase‐like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2014-11, Vol.60 (5), p.1645-1658

2014

Volltextzugriff (PDF)

HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2019-05, Vol.69 (5), p.2013-2030

2019

Volltextzugriff (PDF)

APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase‐independent activity

Molecular carcinogenesis, 2019-05, Vol.58 (5), p.643-653

2019

Volltextzugriff (PDF)

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2021-01, Vol.73 (1), p.23-40

2021

Volltextzugriff (PDF)

Lymphoepithelioma‐like neoplasm of the biliary tract with ‘probable low malignant potential’

Histopathology, 2022-03, Vol.80 (4), p.720-728

2022

Volltextzugriff (PDF)

MicroRNA‐125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2

Hepatology (Baltimore, Md.), 2010-11, Vol.52 (5), p.1731-1740

2010

Volltextzugriff (PDF)

Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b

Liver international, 2015-05, Vol.35 (5), p.1597-1606

2015

Volltextzugriff (PDF)

Hepatic IFIT3 predicts interferon‐α therapeutic response in patients of hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2017-07, Vol.66 (1), p.152-166

2017

Volltextzugriff (PDF)

Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2019-04, Vol.69 (4), p.1768-1786

2019

Volltextzugriff (PDF)

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2022-07, Vol.76 (1), p.48-65

2022

Volltextzugriff (PDF)

Molecular pathogenesis of hepatocellular carcinoma

Liver international, 2008-02, Vol.28 (2), p.160-174

2008

Volltextzugriff (PDF)

Deregulated GATA6 modulates stem cell‐like properties and metabolic phenotype in hepatocellular carcinoma

International journal of cancer, 2019-10, Vol.145 (7), p.1860-1873

2019

Volltextzugriff (PDF)

CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling

Hepatology (Baltimore, Md.), 2012-03, Vol.55 (3), p.807-820

2012

Volltextzugriff (PDF)

Histone lysine methyltransferase, suppressor of variegation 3‐9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA‐125b

Hepatology (Baltimore, Md.), 2013-02, Vol.57 (2), p.637-647

2013

Volltextzugriff (PDF)

Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species

Hepatology (Baltimore, Md.), 2021-08, Vol.74 (2), p.776-796

2021

Volltextzugriff (PDF)

Rho‐kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion

Hepatology (Baltimore, Md.), 2009-05, Vol.49 (5), p.1583-1594

2009

Volltextzugriff (PDF)

Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma

Liver transplantation, 2005-09, Vol.11 (9), p.1086-1092

2005

Volltextzugriff (PDF)

1 – 25 von 205

Suche als RSS-Feed

Aktive Filter

KollektionSociological Abstracts

KollektionWiley Online Library Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(204)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(153)
Humans
(136)
Male
(83)
Gastroenterology & Hepatology
(80)
Female
(78)
Adult
(65)
Biological And Medical Sciences
(61)
Medical Sciences
(59)
Middle Aged
(58)
Tumors
(58)
Liver Neoplasms - Pathology
(56)
Hepatocellular Carcinoma
(55)
Carcinoma, Hepatocellular - Pathology
(53)
Aged
(51)
Gastroenterology. Liver. Pancreas. Abdomen
(42)
Animals
(40)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(40)
Liver Cancer
(33)
Carcinoma, Hepatocellular - Metabolism
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2

Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma

Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26

Aberrant Super‐Enhancer Landscape in Human Hepatocellular Carcinoma

Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma

Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis

C‐terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by c‐jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma

Up‐regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis

Lysyl oxidase‐like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma

HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma

APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase‐independent activity

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma

Lymphoepithelioma‐like neoplasm of the biliary tract with ‘probable low malignant potential’

MicroRNA‐125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2

Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b

Hepatic IFIT3 predicts interferon‐α therapeutic response in patients of hepatocellular carcinoma

Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma

Molecular pathogenesis of hepatocellular carcinoma

Deregulated GATA6 modulates stem cell‐like properties and metabolic phenotype in hepatocellular carcinoma

CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling

Histone lysine methyltransferase, suppressor of variegation 3‐9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA‐125b

Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species

Rho‐kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion

Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma

Aktive Filter

Suchergebnisse filtern